The Immune Underpinnings of Barrett’s-Associated Adenocarcinogenesis: a Retrial of Nefarious Immunologic Co-Conspirators

por Tambunting, Louisa, Kelleher, Dermot, Duggan, Shane Patrick
Publicado 2022

Combination Therapy Using Inhalable GapmeR and Recombinant ACE2 for COVID-19

por Verma, Navin Kumar, Fazil, Mobashar Hussain Urf Turabe, Duggan, Shane P., Kelleher, Dermot
Publicado 2020

Deoxycholate induces COX-2 expression via Erk1/2-, p38-MAPK and AP-1-dependent mechanisms in esophageal cancer cells

por Looby, Eileen, Abdel-Latif, Mohamed MM, Athié-Morales, Veronica, Duggan, Shane, Long, Aideen, Kelleher, Dermot
Publicado 2009

High Content Imaging of Barrett’s-Associated High-Grade Dysplasia Cells After siRNA Library Screening Reveals Acid-Responsive Regulators of Cellular Transitions

por Phipps, Sinead M., Garry, Catherine E., Kamal, Sepehr, Johnson, James D., Gilmer, John, Long, Aideen, Kelleher, Dermot, Duggan, Shane P.
Publicado 2020

The characterization of an intestine-like genomic signature maintained during Barrett’s-associated adenocarcinogenesis reveals an NR5A2-mediated promotion of cancer cell survival

por Duggan, Shane P., Behan, Fiona M., Kirca, Murat, Zaheer, Abdul, McGarrigle, Sarah A., Reynolds, John V., Vaz, Gisela M. F., Senge, Mathias O., Kelleher, Dermot
Publicado 2016

Corrigendum: The characterization of an intestine-like genomic signature maintained during Barrett’s-associated adenocarcinogenesis reveals an NR5A2-mediated promotion of cancer ce...

por Duggan, Shane P., Behan, Fiona M., Kirca, Murat, Zaheer, Abdul, McGarrigle, Sarah A., Reynolds, John V., Vaz, Gisela M. F., Senge, Mathias O., Kelleher, Dermot
Publicado 2016

Obstacles for T-lymphocytes in the tumour microenvironment: Therapeutic challenges, advances and opportunities beyond immune checkpoint

por Verma, Navin Kumar, Wong, Brandon Han Siang, Poh, Zhi Sheng, Udayakumar, Aiswarya, Verma, Ritu, Goh, Ryan Kwang Jin, Duggan, Shane P., Shelat, Vishalkumar G., Chandy, K. George, Grigoropoulos, Nicholas Francis
Publicado 2022

siRNA Library Screening Identifies a Druggable Immune-Signature Driving Esophageal Adenocarcinoma Cell Growth

por Duggan, Shane P., Garry, Catherine, Behan, Fiona M., Phipps, Sinead, Kudo, Hiromi, Kirca, Murat, Zaheer, Abdul, McGarrigle, Sarah, Reynolds, John V., Goldin, Robert, Kalloger, Steve E., Schaeffer, David F., Long, Aideen, Strid, Jessica, Kelleher, Dermot
Publicado 2018